Changes in prevalence of and prescribing for Ischaemic heart disease in Ireland 1990–2002
Authors:
- 1 July 2005
- journal article
- research article
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 174 (3) , 4-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Explaining the Decline in Coronary Heart Disease Mortality in England and Wales Between 1981 and 2000Circulation, 2004
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Pharmacoepidemiology—an Irish perspectivePharmacoepidemiology and Drug Safety, 2001
- Is the prevalence of coronary heart disease falling in British men?Heart, 2001
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- 1999 Update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and RecommendationsCirculation, 1999
- beta Blockade after myocardial infarction: systematic review and meta regression analysisBMJ, 1999
- The Influence of Hospital-Based Prescribers on Prescribing in General PracticePharmacoEconomics, 1999
- The Treatment Gap in Coronary Artery Disease and Heart Failure: Community Standards and the Post-Discharge PatientThe American Journal of Cardiology, 1997
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994